Patent · US Active

Mammalian expression vector

US9422574B2 · kind B2 · utility

0Cited by

1References

1Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Hans-Peter Knopf · Schallstadt, DE
Burkhard Wilms · Weil am Rhein, DE

Key dates

Filing date	May 29, 2012
Grant date	Aug 23, 2016
Priority date	—
Expiry date	May 29, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N15/85
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The invention provides vector nucleic acid for expressing at least one polypeptide of interest in a mammalian cell, comprising Also provided are host cells, comprising said vector and methods for producing a polypeptide using respective host cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.